- call +1-201-465-4211
- email sales@mrinsights.biz
The term biobetter refers to a recombinant protein drug that is in the same class as an existing biopharmaceutical but is not identical; it is improved over the original. Biobetters build on the success of existing, approved biologics but are considered less of a commercial risk than developing a brand new class of biologic.
Scope of the Report:
This report studies the Biobetters market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biobetters market by product type and applications/end industries.
Biobetters are more effective than any other biological entities, the demand of biobetters is much higher as the target action is high and the players are working on development of biobetters in large scale to increase the product availability and also investing larger share in innovation to come up with various product segment for multiple application. Biobetters are very help full in novel biological developing for treating disease such as anemia, prevention of bleeding incidents in children, adult suffering from haemophilia A, cancer and other related problems. As the disease prevalence is increase and various break-out are occurring in various region which cause multiple disorder to populations. The biobetters help in bioengineering to develop product platform for product development in treating diseases.
The global Biobetters market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biobetters.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
OPKO
Abzena
Arecor
GLYCOTOPE
CEVEC
Antares Pharma
Amgen
Novo Nordisk
Roche
Biogen
Pfizer
Eli Lilly
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diabetes
Growth Hormone
Cancer
Renal Disease
Others
Market Segment by Applications, can be divided into
Biopharmaceutical
Contract Research Organizations
Research Institutes
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biobetters Market Overview
1.1 Product Overview and Scope of Biobetters
1.2 Classification of Biobetters by Types
1.2.1 Global Biobetters Revenue Comparison by Types (2017-2023)
1.2.2 Global Biobetters Revenue Market Share by Types in 2017
1.2.3 Diabetes
1.2.4 Growth Hormone
1.2.5 Cancer
1.2.6 Renal Disease
1.2.7 Others
1.3 Global Biobetters Market by Application
1.3.1 Global Biobetters Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Biopharmaceutical
1.3.3 Contract Research Organizations
1.3.4 Research Institutes
1.4 Global Biobetters Market by Regions
1.4.1 Global Biobetters Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biobetters Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biobetters Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biobetters Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biobetters Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biobetters Status and Prospect (2013-2023)
1.5 Global Market Size of Biobetters (2013-2023)
2 Manufacturers Profiles
2.1 OPKO
2.1.1 Business Overview
2.1.2 Biobetters Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 OPKO Biobetters Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abzena
2.2.1 Business Overview
2.2.2 Biobetters Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abzena Biobetters Revenue, Gross Margin and Market Share (2016-2017)
2.3 Arecor
2.3.1 Business Overview
2.3.2 Biobetters Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Arecor Biobetters Revenue, Gross Margin and Market Share (2016-2017)
2.4 GLYCOTOPE
2.4.1 Business Overview
2.4.2 Biobetters Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GLYCOTOPE Biobetters Revenue, Gross Margin and Market Share (2016-2017)
2.5 CEVEC
2.5.1 Business Overview
2.5.2 Biobetters Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CEVEC Biobetters Revenue, Gross Margin and Market Share (2016-2017)
2.6 Antares Pharma
2.6.1 Business Overview
2.6.2 Biobetters Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Antares Pharma Biobetters Revenue, Gross Margin and Market Share (2016-2017)
2.7 Amgen
2.7.1 Business Overview
2.7.2 Biobetters Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Amgen Biobetters Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novo Nordisk
2.8.1 Business Overview
2.8.2 Biobetters Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novo Nordisk Biobetters Revenue, Gross Margin and Market Share (2016-2017)
2.9 Roche
2.9.1 Business Overview
2.9.2 Biobetters Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Roche Biobetters Revenue, Gross Margin and Market Share (2016-2017)
2.10 Biogen
2.10.1 Business Overview
2.10.2 Biobetters Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Biogen Biobetters Revenue, Gross Margin and Market Share (2016-2017)
2.11 Pfizer
2.11.1 Business Overview
2.11.2 Biobetters Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Pfizer Biobetters Revenue, Gross Margin and Market Share (2016-2017)
2.12 Eli Lilly
2.12.1 Business Overview
2.12.2 Biobetters Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Eli Lilly Biobetters Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biobetters Market Competition, by Players
3.1 Global Biobetters Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biobetters Players Market Share
3.2.2 Top 10 Biobetters Players Market Share
3.3 Market Competition Trend
4 Global Biobetters Market Size by Regions
4.1 Global Biobetters Revenue and Market Share by Regions
4.2 North America Biobetters Revenue and Growth Rate (2013-2018)
4.3 Europe Biobetters Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biobetters Revenue and Growth Rate (2013-2018)
4.5 South America Biobetters Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biobetters Revenue and Growth Rate (2013-2018)
5 North America Biobetters Revenue by Countries
5.1 North America Biobetters Revenue by Countries (2013-2018)
5.2 USA Biobetters Revenue and Growth Rate (2013-2018)
5.3 Canada Biobetters Revenue and Growth Rate (2013-2018)
5.4 Mexico Biobetters Revenue and Growth Rate (2013-2018)
6 Europe Biobetters Revenue by Countries
6.1 Europe Biobetters Revenue by Countries (2013-2018)
6.2 Germany Biobetters Revenue and Growth Rate (2013-2018)
6.3 UK Biobetters Revenue and Growth Rate (2013-2018)
6.4 France Biobetters Revenue and Growth Rate (2013-2018)
6.5 Russia Biobetters Revenue and Growth Rate (2013-2018)
6.6 Italy Biobetters Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biobetters Revenue by Countries
7.1 Asia-Pacific Biobetters Revenue by Countries (2013-2018)
7.2 China Biobetters Revenue and Growth Rate (2013-2018)
7.3 Japan Biobetters Revenue and Growth Rate (2013-2018)
7.4 Korea Biobetters Revenue and Growth Rate (2013-2018)
7.5 India Biobetters Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biobetters Revenue and Growth Rate (2013-2018)
8 South America Biobetters Revenue by Countries
8.1 South America Biobetters Revenue by Countries (2013-2018)
8.2 Brazil Biobetters Revenue and Growth Rate (2013-2018)
8.3 Argentina Biobetters Revenue and Growth Rate (2013-2018)
8.4 Colombia Biobetters Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biobetters by Countries
9.1 Middle East and Africa Biobetters Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biobetters Revenue and Growth Rate (2013-2018)
9.3 UAE Biobetters Revenue and Growth Rate (2013-2018)
9.4 Egypt Biobetters Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biobetters Revenue and Growth Rate (2013-2018)
9.6 South Africa Biobetters Revenue and Growth Rate (2013-2018)
10 Global Biobetters Market Segment by Type
10.1 Global Biobetters Revenue and Market Share by Type (2013-2018)
10.2 Global Biobetters Market Forecast by Type (2018-2023)
10.3 Diabetes Revenue Growth Rate (2013-2023)
10.4 Growth Hormone Revenue Growth Rate (2013-2023)
10.5 Cancer Revenue Growth Rate (2013-2023)
10.6 Renal Disease Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 Global Biobetters Market Segment by Application
11.1 Global Biobetters Revenue Market Share by Application (2013-2018)
11.2 Biobetters Market Forecast by Application (2018-2023)
11.3 Biopharmaceutical Revenue Growth (2013-2018)
11.4 Contract Research Organizations Revenue Growth (2013-2018)
11.5 Research Institutes Revenue Growth (2013-2018)
12 Global Biobetters Market Size Forecast (2018-2023)
12.1 Global Biobetters Market Size Forecast (2018-2023)
12.2 Global Biobetters Market Forecast by Regions (2018-2023)
12.3 North America Biobetters Revenue Market Forecast (2018-2023)
12.4 Europe Biobetters Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biobetters Revenue Market Forecast (2018-2023)
12.6 South America Biobetters Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biobetters Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biobetters Picture
Table Product Specifications of Biobetters
Table Global Biobetters and Revenue (Million USD) Market Split by Product Type
Figure Glob
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
